Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies

Amol Prakash, Taha Rezai, Bryan Krastins, David Sarracino, Michael Athanas, Paul Russo, Hui Zhang, Yuan Tian, Yan Li, Vathany Kulasingam, Andrei Drabovich, Christopher R. Smith, Ihor Batruch, Paul E. Oran, Claudia Fredolini, Alessandra Luchini, Lance Liotta, Emanuel Petricoin, Eleftherios P. Diamandis, Daniel W. ChanRandall Nelson, Mary F. Lopez

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Over the past few years, mass spectrometry has emerged as a technology to complement and potentially replace standard immunoassays in routine clinical core laboratories. Application of mass spectrometry to protein and peptide measurement can provide advantages including high sensitivity, the ability to multiplex analytes, and high specificity at the amino acid sequence level. In our previous study, we demonstrated excellent reproducibility of mass spectrometry-selective reaction monitoring (MS-SRM) assays when applying standardized standard operating procedures (SOPs) to measure synthetic peptides in a complex sample, as lack of reproducibility has been a frequent criticism leveled at the use of mass spectrometers in the clinical laboratory compared to immunoassays. Furthermore, an important caveat of SRM-based assays for proteins is that many low-abundance analytes require some type of enrichment before detection with MS. This adds a level of complexity to the procedure and the potential for irreproducibility increases, especially across different laboratories with different operators. The purpose of this study was to test the interlaboratory reproducibility of SRM assays with various upfront enrichment strategies and different types of clinical samples (representing real-world body fluids commonly encountered in routine clinical laboratories). Three different, previously published enrichment strategies for low-abundance analytes and a no-enrichment strategy for high-abundance analytes were tested across four different laboratories using different liquid chromatography-SRM (LC-SRM) platforms and previously developed SOPs. The results demonstrated that these assays were indeed reproducible with coefficients of variation of less than 30% for the measurement of important clinical proteins across all four laboratories in real world samples.

Original languageEnglish (US)
Pages (from-to)3986-3995
Number of pages10
JournalJournal of Proteome Research
Volume11
Issue number8
DOIs
StatePublished - Aug 3 2012

Fingerprint

Assays
Clinical laboratories
Mass spectrometry
Monitoring
Mass Spectrometry
Immunoassay
Peptides
Proteins
Body fluids
Liquid chromatography
Mass spectrometers
Body Fluids
Amino Acids
Liquid Chromatography
Amino Acid Sequence
Technology

Keywords

  • clinical assay
  • mass spectrometry
  • proteomics
  • SRM assay

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Prakash, A., Rezai, T., Krastins, B., Sarracino, D., Athanas, M., Russo, P., ... Lopez, M. F. (2012). Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. Journal of Proteome Research, 11(8), 3986-3995. https://doi.org/10.1021/pr300014s

Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. / Prakash, Amol; Rezai, Taha; Krastins, Bryan; Sarracino, David; Athanas, Michael; Russo, Paul; Zhang, Hui; Tian, Yuan; Li, Yan; Kulasingam, Vathany; Drabovich, Andrei; Smith, Christopher R.; Batruch, Ihor; Oran, Paul E.; Fredolini, Claudia; Luchini, Alessandra; Liotta, Lance; Petricoin, Emanuel; Diamandis, Eleftherios P.; Chan, Daniel W.; Nelson, Randall; Lopez, Mary F.

In: Journal of Proteome Research, Vol. 11, No. 8, 03.08.2012, p. 3986-3995.

Research output: Contribution to journalArticle

Prakash, A, Rezai, T, Krastins, B, Sarracino, D, Athanas, M, Russo, P, Zhang, H, Tian, Y, Li, Y, Kulasingam, V, Drabovich, A, Smith, CR, Batruch, I, Oran, PE, Fredolini, C, Luchini, A, Liotta, L, Petricoin, E, Diamandis, EP, Chan, DW, Nelson, R & Lopez, MF 2012, 'Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies', Journal of Proteome Research, vol. 11, no. 8, pp. 3986-3995. https://doi.org/10.1021/pr300014s
Prakash, Amol ; Rezai, Taha ; Krastins, Bryan ; Sarracino, David ; Athanas, Michael ; Russo, Paul ; Zhang, Hui ; Tian, Yuan ; Li, Yan ; Kulasingam, Vathany ; Drabovich, Andrei ; Smith, Christopher R. ; Batruch, Ihor ; Oran, Paul E. ; Fredolini, Claudia ; Luchini, Alessandra ; Liotta, Lance ; Petricoin, Emanuel ; Diamandis, Eleftherios P. ; Chan, Daniel W. ; Nelson, Randall ; Lopez, Mary F. / Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. In: Journal of Proteome Research. 2012 ; Vol. 11, No. 8. pp. 3986-3995.
@article{f4833629ef2949afabcf076e78c703da,
title = "Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies",
abstract = "Over the past few years, mass spectrometry has emerged as a technology to complement and potentially replace standard immunoassays in routine clinical core laboratories. Application of mass spectrometry to protein and peptide measurement can provide advantages including high sensitivity, the ability to multiplex analytes, and high specificity at the amino acid sequence level. In our previous study, we demonstrated excellent reproducibility of mass spectrometry-selective reaction monitoring (MS-SRM) assays when applying standardized standard operating procedures (SOPs) to measure synthetic peptides in a complex sample, as lack of reproducibility has been a frequent criticism leveled at the use of mass spectrometers in the clinical laboratory compared to immunoassays. Furthermore, an important caveat of SRM-based assays for proteins is that many low-abundance analytes require some type of enrichment before detection with MS. This adds a level of complexity to the procedure and the potential for irreproducibility increases, especially across different laboratories with different operators. The purpose of this study was to test the interlaboratory reproducibility of SRM assays with various upfront enrichment strategies and different types of clinical samples (representing real-world body fluids commonly encountered in routine clinical laboratories). Three different, previously published enrichment strategies for low-abundance analytes and a no-enrichment strategy for high-abundance analytes were tested across four different laboratories using different liquid chromatography-SRM (LC-SRM) platforms and previously developed SOPs. The results demonstrated that these assays were indeed reproducible with coefficients of variation of less than 30{\%} for the measurement of important clinical proteins across all four laboratories in real world samples.",
keywords = "clinical assay, mass spectrometry, proteomics, SRM assay",
author = "Amol Prakash and Taha Rezai and Bryan Krastins and David Sarracino and Michael Athanas and Paul Russo and Hui Zhang and Yuan Tian and Yan Li and Vathany Kulasingam and Andrei Drabovich and Smith, {Christopher R.} and Ihor Batruch and Oran, {Paul E.} and Claudia Fredolini and Alessandra Luchini and Lance Liotta and Emanuel Petricoin and Diamandis, {Eleftherios P.} and Chan, {Daniel W.} and Randall Nelson and Lopez, {Mary F.}",
year = "2012",
month = "8",
day = "3",
doi = "10.1021/pr300014s",
language = "English (US)",
volume = "11",
pages = "3986--3995",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies

AU - Prakash, Amol

AU - Rezai, Taha

AU - Krastins, Bryan

AU - Sarracino, David

AU - Athanas, Michael

AU - Russo, Paul

AU - Zhang, Hui

AU - Tian, Yuan

AU - Li, Yan

AU - Kulasingam, Vathany

AU - Drabovich, Andrei

AU - Smith, Christopher R.

AU - Batruch, Ihor

AU - Oran, Paul E.

AU - Fredolini, Claudia

AU - Luchini, Alessandra

AU - Liotta, Lance

AU - Petricoin, Emanuel

AU - Diamandis, Eleftherios P.

AU - Chan, Daniel W.

AU - Nelson, Randall

AU - Lopez, Mary F.

PY - 2012/8/3

Y1 - 2012/8/3

N2 - Over the past few years, mass spectrometry has emerged as a technology to complement and potentially replace standard immunoassays in routine clinical core laboratories. Application of mass spectrometry to protein and peptide measurement can provide advantages including high sensitivity, the ability to multiplex analytes, and high specificity at the amino acid sequence level. In our previous study, we demonstrated excellent reproducibility of mass spectrometry-selective reaction monitoring (MS-SRM) assays when applying standardized standard operating procedures (SOPs) to measure synthetic peptides in a complex sample, as lack of reproducibility has been a frequent criticism leveled at the use of mass spectrometers in the clinical laboratory compared to immunoassays. Furthermore, an important caveat of SRM-based assays for proteins is that many low-abundance analytes require some type of enrichment before detection with MS. This adds a level of complexity to the procedure and the potential for irreproducibility increases, especially across different laboratories with different operators. The purpose of this study was to test the interlaboratory reproducibility of SRM assays with various upfront enrichment strategies and different types of clinical samples (representing real-world body fluids commonly encountered in routine clinical laboratories). Three different, previously published enrichment strategies for low-abundance analytes and a no-enrichment strategy for high-abundance analytes were tested across four different laboratories using different liquid chromatography-SRM (LC-SRM) platforms and previously developed SOPs. The results demonstrated that these assays were indeed reproducible with coefficients of variation of less than 30% for the measurement of important clinical proteins across all four laboratories in real world samples.

AB - Over the past few years, mass spectrometry has emerged as a technology to complement and potentially replace standard immunoassays in routine clinical core laboratories. Application of mass spectrometry to protein and peptide measurement can provide advantages including high sensitivity, the ability to multiplex analytes, and high specificity at the amino acid sequence level. In our previous study, we demonstrated excellent reproducibility of mass spectrometry-selective reaction monitoring (MS-SRM) assays when applying standardized standard operating procedures (SOPs) to measure synthetic peptides in a complex sample, as lack of reproducibility has been a frequent criticism leveled at the use of mass spectrometers in the clinical laboratory compared to immunoassays. Furthermore, an important caveat of SRM-based assays for proteins is that many low-abundance analytes require some type of enrichment before detection with MS. This adds a level of complexity to the procedure and the potential for irreproducibility increases, especially across different laboratories with different operators. The purpose of this study was to test the interlaboratory reproducibility of SRM assays with various upfront enrichment strategies and different types of clinical samples (representing real-world body fluids commonly encountered in routine clinical laboratories). Three different, previously published enrichment strategies for low-abundance analytes and a no-enrichment strategy for high-abundance analytes were tested across four different laboratories using different liquid chromatography-SRM (LC-SRM) platforms and previously developed SOPs. The results demonstrated that these assays were indeed reproducible with coefficients of variation of less than 30% for the measurement of important clinical proteins across all four laboratories in real world samples.

KW - clinical assay

KW - mass spectrometry

KW - proteomics

KW - SRM assay

UR - http://www.scopus.com/inward/record.url?scp=84864583363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864583363&partnerID=8YFLogxK

U2 - 10.1021/pr300014s

DO - 10.1021/pr300014s

M3 - Article

C2 - 22639787

AN - SCOPUS:84864583363

VL - 11

SP - 3986

EP - 3995

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 8

ER -